Skip to main content
RTW Biotech Opportunities Ltd logo

RTW Biotech Opportunities Ltd — Investor Relations & Filings

Ticker · RTW ISIN · GG00BKTRRM22 LEI · 549300Q7EXQQH6KF7Z84 IL Financial and insurance activities
Open in API
Filings indexed 544 across all filing types
Latest filing 2026-04-24 Transaction in Own Shar…
Country GG Guernsey
Listing IL RTW

About RTW Biotech Opportunities Ltd

https://www.rtwfunds.com/rtw-biotech-op…

RTW Biotech Opportunities Ltd is an investment fund that focuses on identifying and investing in transformative assets with high growth potential across the global life sciences sector. The company's portfolio is primarily composed of biotechnology and medical technology companies. Managed by RTW Investments, LP, a specialized life sciences investment firm, the fund leverages deep scientific expertise to support companies throughout their entire lifecycle, from early-stage private ventures to publicly traded entities. The investment strategy aims to provide capital and strategic support to advance the development of innovative therapies and technologies.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 97% confidence The document is an RNS (‘Regulatory News Service’) announcement by RTW Biotech Opportunities Ltd detailing that the company bought back 250,000 of its Ordinary Shares, held in treasury, and provides updated issued share capital and voting rights. This is a company share repurchase (buy-back) announcement, which falls squarely under the ‘Transaction in Own Shares’ category (Code: POS).
2026-04-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is an RNS announcement by RTW Biotech Opportunities Ltd detailing the repurchase of its own ordinary shares (buyback of 76,212 shares, treasury holdings, voting rights impact). This matches the definition for “Transaction in Own Shares.”
2026-04-21 English
Kailera completes $625 million IPO
Capital/Financing Update Classification · 85% confidence The document is an RNS press release announcing the successful $625 million IPO of Kailera, a private portfolio company of RTW Biotech Opportunities Ltd. It details the financing event (IPO proceeds, valuation uplifts, NAV impact) rather than earnings, management changes, or legal matters. This is clearly an update on a fundraising/capital transaction, which matches the Capital/Financing Update category.
2026-04-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 92% confidence The document is an RNS announcement titled “Transaction in Own Shares” describing the company’s buyback of 100,000 ordinary shares held in treasury and detailing share counts and voting rights. This directly matches the definition for category 29: Transaction in Own Shares (POS).
2026-04-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 98% confidence The document is an RNS announcement titled “Transaction in Own Shares,” detailing a share buyback by RTW Biotech Opportunities Ltd, including the number of shares purchased, treasury details, voting rights, authority, and broker information. This clearly corresponds to the company’s repurchase of its own shares, fitting the “Transaction in Own Shares” category.
2026-04-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is a Regulatory News Service (RNS) announcement titled “Transaction in Own Shares,” detailing the company’s buyback of 100,000 ordinary shares into treasury and updated voting rights. This corresponds exactly to a share repurchase announcement. According to the filing definitions, this falls under “Transaction in Own Shares” (Code: POS).
2026-04-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.